You don't need to be signed in to read BMJ Group Blogs, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Richard Smith: A short history of patient power

11 Jul, 11 | by BMJ Group

Richard SmithI urge you to read Michael Millenson’s article on “Spock, Feminists, and the Fight for Participatory Medicine: a History.” It’s a fascinating and very readable account of how patient power has steadily increased in the US, and it would be very good to have a similar history in Britain.

Most of what follows in this blog comes from Millenson’s article to give you taste of the pleasure you’ll get from reading it—and, I suppose, a quick summary for those without the appetite for 3000 words.

The original code of ethics of the American Medical Association (AMA) said: “the obedience of a patient to the prescriptions of his physician should be prompt and implicit. [The patient] should never permit his own crude opinions as to their fitness to influence his attention to them.”  This was, of course, at a time when many prescriptions were both ineffective and harmful.

Millenson argues that it was Dr Spock who changed the traditional view for ever when he spoke at the AMA centenary meeting in 1947. Criticising doctors who gave mothers detailed schedules on when to feed their babies, he advocated feeding them when they seemed hungry “irrespective of the hour.” Mothers deciding when to feed their babies was, he said, “obviously nature’s own [method],which was used by the entire human race until the turn of the century.”

An earlier turning point in the rise of patient power came in a Supreme Court judgement on the case of an epileptic woman who had her uterus and ovaries removed without her consent. In 1905 the court prohibited a doctor “however skilful or eminent
to violate without permission
the bodily integrity of his patient
and [to operate] on him without his consent or knowledge.” A 1914 judgement said that it was assault for a doctor to do so.

Despite these judgements it wasn’t until the 50s that patients won the right to be fully informed on the benefits and risks of what the doctor planned to do, and only very recently have the courts made clear that the patient has the right to know not just about what the doctor plans to do but also about alternative options.

While the law worried away at the problem, 12 Boston feminists “frustrated and angered
by not having a say in our own health care” published Women and Their Bodies, which sold 200 000 copies and led to Our Bodies, Ourselves, which sold millions of copies. It argued that “women can become their own health experts.”

Inspired by the civil rights movement the women began to talk of patients’ rights and created alternative birthing centres that demedicalised birth and spread rapidly across the US.

The AIDS pandemic in the 80s led to completely new levels of patient participation in their care as “gay activists immersed themselves in the clinical details of AIDS research” and “asserted that the disease, no matter how deadly, was less important than the person harbouring it.”

The work of Jack Wennberg on variations in practice showed that much of health care is driven not by evidence but by “physician preference” and led to the creation of the Foundation for Informed Decision Making that aims to arm patients to become partners in their care.

The arrival of the internet has given a tremendous boost to patient power, and in 2001 the Institute of Medicine concluded that involving patients in decisions about their care was “the right thing to do ethically, provided better outcomes clinically, and was socially unavoidable” because of the explosion of information on the internet.

The global reality is, however, very different with doctors in many countries still practising in a paternalistic even dictatorial manner as if Our Bodies, Ourselves had never been written. We need further change, and a global history of patient participation would be an important step.

Richard Smith was the editor of the BMJ until 2004 and is director of the United Health Group’s chronic disease initiative.

By submitting your comment you agree to adhere to these terms and conditions
  • http://twitter.com/R_Hughes1 Rob Hughes

    Thanks. Really interesting, and clearly this is a vital issue, and the agenda on moving away from paternalism is far from over in the UK, US or further afield. 

    I was interested in your point in the first paragraph suggesting that a similar history for the UK would be good. Did you mean a similar narrative/story about the key events, or are you implying that the UK needs to catch up with the US on this..? 

    If the latter, then I would tend to disagree. I think there are many many ways in which the 'consumers' in the US are given less agency than patients in the UK, and there are interesting systemic determinants of this.

  • Richard Smith

    I meant simply that Britain needs a similar history. Whether Britain is ahead or behind the US in ecouraging patient participation is uncertain, but the USdoes have a more powefful consumer movement.

  • Andrew K

    The medical profession does indeed need to increase patient participation, not just in terms of clinical choices, but research choices as well.

    Some diseases are consistently neglected compared to others.

    What will it take to make the medical profession take Chronic Fatigue Syndrome more seriously?

    The NIH (USA) provides figures on the amount of research funding spent on each condition. http://report.nih.gov/rcdc/cat…
    If you compare the levels of societal economic costs and disability (and especially when considering combined metrics such as DALYs).

    The annual economic costs are not cheap:
    CFS $19-24 billion http://www.dynamic-med.com/con…
    (or $51 billion using much looser CDC empirical definition of CFS http://www.ncbi.nlm.nih.gov/pu… )
    NIH (USA) research spending in 2011: $6 million

    Comparison with other diseases:
    Obesity – $59 billion economic costs (inflation adjusted)
    http://www.ajcn.org/content/55… – $823 million in NIH research spending

    Autism – $38 billion economic costs (inflation adjusted)
    http://archpedi.ama-assn.org/c… – $160 million in NIH spending

    Diabetes – $174 billion
    http://care.diabetesjournals.o… – $1,044 million in NIH spending

    If you do the math, the disease is under-funded by between 15-50 times compared to these other diseases. (using a mean estimate of of $21.5 billion dollars for CFS)

    Unfortunately the condition has been even more poorly funded in the UK and other western countries.

    Advocates/patients have been saying the same thing for a long time: we need more biomedical research.

    All they are rewarded with is a few good studies by a handful of dedicated researchers who's motivation is often a personal one

    But on the clinical front, instead of highly efficacious treatments, patients are just given CBT and GET and told to be on their way.
    But unfortunately there is no evidence to suggest those treatments lead to cure at all. Or even objective increases in activity levels at follow ups using actometer measurements or hours spent in employment related activities as a proxy.
    http://www.ncbi.nlm.nih.gov/pu… (meta-review of actometer measurements after CBT found no mean change in activity levels)

    Hence why in the published results of the PACE trial, the authors didn't even bother to publish the rates of recovery, or the Client Service Receipt Inventory data, which was the only objective measure of disability/activity levels. Despite those measures being integral parts of the scientific protocol that they had published earlier.
    http://www.biomedcentral.com/1… (protocol)
    http://www.thelancet.com/journ… (results)

    But unfortunately, patients don't recover on their own either:
    http://occmed.oxfordjournals.o… (systematic review of recovery rates)

    For this disease, the only hope of patients to reduce disability so that they can go back to work and participate in their family again is further research. But we are not researching this disease on an equitable level compared to other diseases.

    When will CFS stop being swept under the carpet? What will it take for patients to be heard?

  • Shing

    This is a refreshing challenge to healthcare practice. Initially i thought such authoritatian, paternistic and even dictatorial ways are only manifested by doctors in developing countries like in Asia. I am challenged to rethink that perhaps its just the personality per se.  I have heard patient complaining that they are afraid of their breast surgery as they heard so much of what her breast surgeon could do – eg telling patient she will do this and cut this but on the table -without patient consent cut more and then justify ' its for your good according to my clinical judgement'.  At first, i rejected patients' complaint as myth, fear and heresay but i had to reconsider when talking to the very breast surgeon herself about herceptin and her comments were “i look at the patient and her ways of dressing, I can tell she is unable to pay and as such  i dont waste my time telling her even about her HER 2 status” . The irony is nothing can be done and such person are even elected as president of asia pacific assoc.  with globalisation, perhaps there is a need for an international ethic board to weed out such practices and harm done  to patients as well as helath care professionals whom these personality 'sees'  as subordinate or below them.

  • Richard Smith

    I'm currently in Nigeria where my Nigerian friends tell me that a doctor doesn't need any kind of insurance or protection to practise–because patients don't complain and no doctor has ever been taken to court for negligence. Yet Nigeria is full of doctors performing surgery way beyond their competence in small, private clinics.
        It's made me think how interesting it would be to have a country by country history of patient power. Here in Nigeria they don't even seem to have recahed the stage that the US reached in 1906.

  • Pip Hardy

    A very interesting piece – thank you for an enlightening rundown on the history of patient participation and interesting comments so far.

    Clearly there have been huge strides in the direction of informing and involving patients in decisions about their care. It still seems that, all too often, patients are not listened to. We at the Patient Voices Programme (http://www.patientvoices.org.uk)  have been listening to, collecting and disseminating the stories of patients as short (2-3 minute) digital stories in the hope that important lessons might be learned. Our precedent was the aviation industry's Aviation Safety Reporting System – an initiative that relied on listening to the stories of pilots about their near misses. Only when these stories were collected and published in a form that was highly accessible to those involved in the industry did aviation start to become safer.

    We need to listen to patients – and their carers if we want to find out what really matters to them and, along the way, improve the quality and safety of healthcare. But if busy professionals cannot spare even two or three minutes to listen to a story, I'm afraid there is little hope for the future of patient participation other than as an activist option – and that is not necessarily what many people want.

    As Robert Francis QC said in his introduction to the mid-Staffs inquiry, it's more important than ever before to listen to the stories patients have to tell us if we really want to find out what's going on. Or, as one Patient Voices storyteller says: 'Health professionals should spend three minutes every day listening to one of these stories. Then they might begin to understand what really matters to patients.'

  • Petra Diaz del Campo

    We have experience involving patients and
    taking into account their preferences developing evidence based Clinical
    Practice Guidelines (CPGs), from the beginning of the process. We are aware the
    importance of patients’ involvement in their own health care, so that’s why we
    are concerned in promoting active patient participation in the decision making process
    about their health. Continuing with this strategy of enhancing patient
    participation and consultation, in our agency (Health Technology Assessment
    Unit of the regional government in Madrid, Spain) we are developing methods and
    tools –patient decision aids- to facilitate sharing the decisions between
    patients and professionals, supporting a ‘shared decision making’ process.
    These decision aids tools are really important to patients, especially when
    there is uncertainty about the outcomes of different options for a specific
    health problem. It is in this context when these aids, with evidence based
    information and decisional balance sheets, help patients to know what their own
    preferences and personals values are, so they can participate with the
    professionals (sharing) improving the quality and the confidence in their own
    decisions.

     

    Thank you very much for spreading such news!

     

    Petra DĂ­az del Campo, Javier Gracia

You can follow any responses to this entry through the RSS 2.0 feed.
BMJ blogs homepage

BMJ.com

Helping doctors make better decisions. Visit site



Creative Comms logo

Latest from BMJ.com

Latest from BMJ.com

Latest from BMJ.com podcasts

Latest from BMJ.com podcasts

Blogs linking here

Blogs linking here